Consent to the Distribution of Changed Medicines Pursuant to section 23 of the Medicines Act 1981, the Minister of Health hereby provisionally consents to the sale, supply or use in New Zealand of the changed medicines which were referred to the Minister of Health under the provisions of section 24 (5) of the Act and are set out in the Schedule hereto: Schedule Name and Strength Form Name and Address of Manufacturer Proprietary Name(if any) Ritonavir 100 mg Capsule, powder filled Abbott Laboratories, Chemical & Agricultural Products Division, North Chicago, Illinois, United States of America and Abbott Laboratories (UK) Limited, Queensborough, Kent, England Norvir Ritonavir 80 mg/mL Solution, oral Abbott Laboratories, Chemical & Agricultural Products Division, North Chicago, Illinois, United States of America and Abbott Laboratories (UK) Limited, Queensborough, Kent, England Norvir Note: This product has provisional consent. Dated this 19th day of January 1999. G. R. BOYD, Chief Advisor, Regulation and Safety, pursuant to delegation given by the Minister of Health on the 20th day of February 1997.